VivoSeq
Other

Dental Pain

0

Pipeline Programs↗

0

Active Trials↗

6

Companies Involved↗

Dental Pain is an early-stage landscape with 0 programs across 6 companies. The most active players are Merck & Co., Pfizer, Iroko Pharmaceuticals, LLC.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalI

Iroko Pharmaceuticals, LLC

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalS

SCOLR Pharma, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

26

clinical trials

Completed23 · 88%
Terminated2 · 8%
Unknown status1 · 4%

Clinical Trials

Trial Activity

26 trials

Study of Naproxen Capsules to Treat Dental Pain
Completed·IIroko Pharmaceuticals, LLC·Phase 2·NCT01229228·254 enrolled
Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain
Completed·Pfizer logoPfizer·Phase 2·NCT00913627·196 enrolled
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00092300·450 enrolled
Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain
Completed·Bayer logoBayer·Phase 3·NCT01280591·712 enrolled
Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain
Completed·—·Phase 2·NCT03410212·60 enrolled
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain
Completed·Pfizer logoPfizer·Phase 3·NCT01098747·335 enrolled
Injectable Diclofenac for the Prevention of Post-operative Dental Pain
Completed·IIBSA Institut Biochimique SA·Phase 2·NCT01706588·75 enrolled
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00092313·271 enrolled
A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain
Completed·Novartis logoNovartis·Phase 3·NCT02476422·328 enrolled
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain
Completed·Pfizer logoPfizer·Phase 3·NCT01216163·218 enrolled
A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)
Completed·—·Phase 3·NCT00694369·588 enrolled
Study of Diclofenac Capsules to Treat Dental Pain
Completed·IIroko Pharmaceuticals, LLC·Phase 2·NCT00985439·202 enrolled
Efficacy Of PF-05089771 In Treating Postoperative Dental Pain
Completed·Pfizer logoPfizer·Phase 2·NCT01529346·235 enrolled
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00092326·269 enrolled
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00092339·125 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)